Regulation of the pathological vasculature of malignant astrocytomas by angiopoietin-1

被引:21
作者
Zadeh, G
Reti, R
Koushan, K
Qian, BP
Shannon, P
Guha, A
机构
[1] Toronto Western Hosp, Dept Pathol, Toronto, ON M5T 2S8, Canada
[2] Univ Toronto, Hosp Sick Children, Arthur & Sonia Labatts Brain Tumor Ctr, Toronto, ON M5G 1X8, Canada
[3] Univ Toronto, Toronto Western Hosp, Div Neurosurg, Toronto, ON M5T 2S8, Canada
来源
NEOPLASIA | 2005年 / 7卷 / 12期
基金
加拿大健康研究院;
关键词
glomeruloid bodies; astrocytoma; angiopoietin; tumor angiogenesis; Tie2; receptor;
D O I
10.1593/neo.05424
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malignant astrocytomas are the most common and highly vascularized of all primary adult brain tumors. The histopathological hallmarks of malignant astrocytomas are microvascular proliferation and formation of vascular entities, which are referred to as "glomeruloid bodies." The significance of glomeruloid bodies and the molecular mechanisms driving the abnormal vascular architecture in malignant astrocytomas are not understood. We have observed that overexpression of angiopoietin-1 (Ang1) in both subcutaneous and intracranial xenograft models of malignant astrocytomas reproduces many of the vascular features of these tumors, including glomeruloid bodies. To confirm that the formation of glomeruloid bodies was directly dependent on Ang1, we performed experiments where levels of Ang1 expression were regulated under tetracycline control, and we found a direct correlation between levels of Ang1 expression and the occurrence of glomeruloid bodies in xenografts. Additionally, we inhibited the action of Ang1 by blocking its cognate receptor Tie2, and we found that the formation of glomeruloid bodies was inhibited. Collectively, these results support our hypothesis that Ang1 is a key molecular regulator of pathological vascularization characteristic of malignant astrocytomas.
引用
收藏
页码:1081 / 1090
页数:10
相关论文
共 41 条
[1]  
Ahmad SA, 2001, CANCER, V92, P1138, DOI 10.1002/1097-0142(20010901)92:5<1138::AID-CNCR1431>3.0.CO
[2]  
2-L
[3]   Expression of angiopoietin-1 in human glioblastomas regulates tumor-induced angiogenesis - In vivo and in vitro studies [J].
Audero, E ;
Cascone, I ;
Zanon, I ;
Previtali, SC ;
Piva, R ;
Schiffer, D ;
Bussolino, F .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) :536-541
[4]   Tumorigenesis and the angiogenic switch [J].
Bergers, G ;
Benjamin, LE .
NATURE REVIEWS CANCER, 2003, 3 (06) :401-410
[5]   Glomeruloid microvascular proliferation orchestrated by VPF/VEGF - A new world of angiogenesis research [J].
Brat, DJ ;
Van Meir, EG .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (03) :789-796
[6]  
BURGER PC, 1994, TUMORS CENTRAL NERVO, V3
[7]  
BURGER PC, 1991, BRAIN TUMORS, P193
[8]   Direct cell adhesion to the angiopoietins mediated by integrins [J].
Carlson, TR ;
Feng, YZ ;
Maisonpierre, PC ;
Mrksich, M ;
Morla, AO .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (28) :26516-26525
[9]   Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen system [J].
Carmeliet, P ;
Moons, L ;
Dewerchin, M ;
Mackman, N ;
Luther, T ;
Breier, G ;
Ploplis, V ;
Muller, M ;
Nagy, A ;
Plow, E ;
Gerard, R ;
Edgington, T ;
Risau, W ;
Collen, D .
ATHEROSCLEROSIS IV: RECENT ADVANCES IN ATHEROSCLEROSIS RESEARCH: THE FOURTH SARATOGA INTERNATIONAL CONFERENCE ON ATHEROSCLEROSIS, 1997, 811 :191-206
[10]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257